Moscow, September 06, 2013 — Pharmstandard OJSC (LSE: PHST LI, MICEX-RTS: PHST RU) («Pharmstandard» or/and the «Company») announces that as a part of the settlement process with regards to the acquisition of Bever Pharmaceutical Pte Ltd (the «Transaction») Pharmstandard-Leksredstva OJSC sold 18.74% (8.81%- ordinary shares, 9.93% — GDRs) of shares in Pharmstandard OJSC to Bristley Enterprises Limited (Cyprus) (‘Bristley»).
As a result Bristley became a c.19% holder of Pharmstandard OJSC.
Pharmstandard-Leksredstva OJSC is no longer a shareholder in Pharmstandard OJSC.
Head of Investor Relations
Tel. (495) 970–0030 ext.2824
Fax (495) 970–0032